Sanofi India Ltd. is a pharmaceutical company based in India with a risk rating score of 25.3, indicating a medium-risk assessment. Specializing in various therapeutic areas such as Diabetes, Cardiology, and Consumer Healthcare, the company also operates in Hospital, Central Nervous System, and Anti-Histamines segments. With a focus on ESG, Sanofi India Ltd. exports products to countries like Germany, the U.K., Australia, and Russia. Leveraging strategic partnerships for growth, the company offers a range of oral anti-diabetic products, insulin, and nutraceuticals in its portfolio.